Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Taskus Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.8 (market cap $4.59B), while Taskus Inc trades at $8.15 (market cap $723.41M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 6.3× Taskus Inc's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Taskus Inc for 34 Days on average.
| DFTX | TASK | |
|---|---|---|
Market Cap | $4.59B | $723.41M |
Volume | 2,103,937 | 201,303 |
Sector | Health | Technology |
52-Week High | $48.45 | $14.69 |
52-Week Low | $10.68 | $4.57 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $3.55B | $1.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TaskUs trades at $8.08, up 2.41% today, with a bearish technical signal but strong fundamentals including a low P/E of 6.8 and robust ROE of 25.43%. Recent Q2 2026 earnings beat estimates with $0.33 EPS versus $0.29 expected, driven by 5% revenue growth to $308.9 million. The company shows consistent cash flow generation with $137 million from operations in 2025.
The stock appears undervalued with analyst consensus target of $9.33 offering 15% upside potential. Key risks include margin compression from higher labor costs and dependence on AI segment growth. Institutional ownership increased with Dimensional Fund Advisors raising its stake by 12.8% in Q1 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
